PubRank

M M Shmarov

Author PubWeight™ 16.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation. Oncogene 2008 1.20
2 Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. Arch Virol 2005 1.11
3 Toll-Like Receptors (TLRs): The Role in Tumor Progression. Acta Naturae 2010 0.91
4 Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53. Gene Ther 2004 0.86
5 Recombinant influenza vaccines. Acta Naturae 2012 0.80
6 Inhibition of influenza A virus reproduction by a ribozyme targeted against PB1 mRNA. Antiviral Res 1999 0.79
7 An Efficient Method for the Delivery of the Interleukin-2 Gene to Human Hematopoietic Cells using the 
Fiber-Modified Recombinant Adenovirus. Acta Naturae 2011 0.78
8 A In Vitro and In Vivo Study of the Ability of NOD1 Ligands to Activate the Transcriptional Factor NF-kB. Acta Naturae 2011 0.78
9 Recombinant avian adenovirus CELO expressing the human interleukin-2: characterization in vitro, in ovo and in vivo. Virus Res 2004 0.78
10 Adenoviral transduction of multipotent mesenchymal stromal cells from human adipose tissue with bone morphogenetic protein BMP-2 gene. Bull Exp Biol Med 2013 0.78
11 [Sequence analysis of hexon gene from adenovirus KR95 inducing hydropericardium syndrome in chickens]. Mol Gen Mikrobiol Virusol 2000 0.78
12 [Construction of the vector based on the CELO avian adenovirus genome providing enhanced expression of secreted alkaline phosphatase gene in a non-permissive system in vitro and in vivo]. Mol Gen Mikrobiol Virusol 2008 0.77
13 [Protective properties of candidate genetically engineered vaccines against avian influenza viruses constructed on the basis of recombinant adenoviral vectors]. Zh Mikrobiol Epidemiol Immunobiol 2010 0.77
14 [The induction of protective immune response in mice vaccinated by recombinant avian adenovirus CELO expressing glycoprotein G of the rabies virus]. Zh Mikrobiol Epidemiol Immunobiol 2006 0.77
15 Toll-like receptors and their adapter molecules. Biochemistry (Mosc) 2010 0.77
16 [Lipid-associated membrane lipopeptides of M. arginini activate NF-kB by interacting with TLR2/1, TLR2/6, and TLR2/CD14]. Mol Gen Mikrobiol Virusol 2009 0.77
17 Gene therapy of amyotrophic lateral sclerosis. Bull Exp Biol Med 2008 0.77
18 [The role of pattern-recognizing receptors in anti-infectious immunity]. Vestn Ross Akad Med Nauk 2011 0.76
19 Analysis of the efficiency of gene-cell therapy in transgenic mice with amyotrophic lateral sclerosis phenotype. Bull Exp Biol Med 2013 0.76
20 Triggering of Toll-like Receptor-2 in Mouse Myelomonocytic Leukaemia Cells WEHI-3B Leads to the Suppression of Apoptosis and Promotes Tumor Progression in Vivo. Acta Naturae 2011 0.76
21 [Advantages and prospects of the use of genetic vaccines for the protection from dangerous and socially significant infections]. Vestn Ross Akad Med Nauk 2011 0.75
22 [Experimental approach to the gene therapy of motor neuron disease with the use of genes hypoxia-inducible factors]. Genetika 2014 0.75
23 [The CELO-ANG recombinant avian adenovirus with human angiogenine gene inducing neovascularization in the anterior tibial muscle of rat]. Mol Gen Mikrobiol Virusol 2004 0.75
24 [An in vivo study of the biologic activity of the recombinant pseudoadenovirus nanostructure containing lactoferrin gene]. Mol Gen Mikrobiol Virusol 2010 0.75
25 [Delivery of secreted placental alkaline phosphatase (SEAP) gene in vitro and in vivo as a component of recombinant avian adenovirus (CELO)]. Mol Gen Mikrobiol Virusol 2002 0.75
26 [Recombinant pseudoadenovirus nanostructure with human lactoferrin gene: production and study of lactoferrin expression and properties in vivo usage of the construction]. Mol Gen Mikrobiol Virusol 2009 0.75
27 [Influence of integrin-binding motif (RGD) on attachment and internalization of avian adenovirus CELO in mammalian cells]. Mol Gen Mikrobiol Virusol 2008 0.75
28 [Identification of Mycoplasma in patients with suspected prostate cancer]. Zh Mikrobiol Epidemiol Immunobiol 2010 0.75
29 [Production of human recombinant beta-interferon in the avian cell culture]. Mol Gen Mikrobiol Virusol 2008 0.75
30 [Mycoplasma M. arginini infection induces constitutive activation of NF-kappaB and inhibits apoptosis in cells expressing toll-like receptors TLR2/6]. Mol Gen Mikrobiol Virusol 2008 0.75
31 [Construction of recombinant adenoviral vector expressing genes of the conservative influenza proteins M2 and nucleoprotein]. Mol Gen Mikrobiol Virusol 2014 0.75